Mr. Tom Glawdel reports

GLOW EXPEDITES PATH TO COMMERCIALIZATION WITH THE UPCOMING LAUNCH OF MULTIPLE IN-HOUSE CANNABIS CONSUMER BRANDS

Glow Lifetech Corp. plans to launch multiple in-house cannabis consumer brands powered by its portfolio of proprietary ingredient technologies. The company expects to commercially deploy its innovative technology and products into the Canadian cannabis market as early as Q3 2023.

"By launching our own in-house CPG brands and products, we are able to expedite the route to market for our proprietary ingredients and ensure an optimal consumer experience, all while demonstrating the success of our technologies in one the largest cannabis markets in the world," said Rob Carducci, chief commercial officer, Glow Lifetech. "We have multiple avenues for value creation and CPG products unlock a new vehicle to build the B2B business, by showcasing our technology in real-world settings and adding additional brand and formulation IP that can be licensed around the world."

"Glow has developed a portfolio of cutting-edge ingredient technologies, in both liquid and powder formats, that gives us incredible flexibility in formulating market-leading cannabis-infused products," said Tom Glawdel, chief operating officer, Glow Lifetech. "We expect the remainder of 2023 to be an impactful time for Glow, as we have a clear path to getting our innovative products onto the marketplace for consumers to start experiencing."

Versatile technology platform

Glow has built a versatile technology platform that allows the company to support a variety of innovative product formats including drops, sprays, capsules, drink mixes, gummies, infused foods and more. The company recently announced it has developed a proprietary, water-soluble cannabis powder technology, which expands the company's technology portfolio to both liquid and powder cannabinoid ingredients (see July 6, 2023, release), building on its existing liquid MyCell technology. Glow's portfolio of water-soluble cannabis ingredients including THC, CBD, CBN and CBG, are designed for optimized absorption, great taste, rapid onset, and a more consistent and predictable cannabis experience.

Multiple growth vectors

Launching its own in-house brands demonstrates how having a flexible technology platform and control over its own proprietary ingredients and brands, provides the company optionality for multiple revenue streams which could include:

• In-house brands: Fully owned CPG brands and products to capture greater margin;
• Technology/IP licensing: licensing delivery technologies, formulations or brands around the world in legal markets;
• Ingredients sales: B2B (business-to-business) sales of proprietary ingredients for use in infused products;
• Development partnerships: projects creating novel formulations and products for strategic partners.

Asset-light operations, built to scale

The company has built an efficient, asset-light cannabis production operation with a factor-in-factory manufacturing partnership in Toronto, Canada, that is designed to scale and minimize operating costs. With the processing facility built and equipment commissioned, it will house all of Glow's cannabis-related R&D (research and development) activities, serving as the company's cannabis production centre of excellence to develop technologies and products for the global market. This single-licensed production location provides the company the necessary production capacity to produce a diverse portfolio of cannabis products to service the Canadian market nationally, across both adult-use and medical cannabis markets.

Glow's goal is to create novel technologies, ingredients and products that offer a competitive advantage to its proprietary brands. Additionally, the company seeks to forge licensing and manufacturing partnerships with strategic allies as part of its vision for global expansion.

We seek Safe Harbor.